KPA under siege

Published: 2012-01-19 07:00:00

Updated: 2012-01-19 07:00:00

The executives of the Korean Pharmaceutical Association — under fire for its decision to agree a plan with the health ministry to allow the sale of non-prescription drugs at places other than pharmacies — is moving to find a way to regain the confidence of member pharmacists in the forthcoming sp...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK